Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03785548 · ClinicalTrials.gov registry record
Utilization of the Mirror During Pelvic Exams
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 147
- Enrollment target
NCT03785548: Completed study, sponsored by TriHealth.
NCT03785548 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 147 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03785548 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 147 participants
- Enrollment target
Study Summary
This is a prospective cohort study to determine if using a birthing mirror during the patient's pelvic examination decreases patients's degree of vulnerability and discomfort.
Primary Outcome
VAS on vulnerability level will be measured after the pelvic exam, and group difference after controlling for baseline vulnerability, will be calculated. The VAS is a validated 100 millimeter scale with 'no vulnerability' represented as 0 mm and 'very vulnerable' equating to 100 mm.
Interventions
- OTHER Usage of a mirror
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2020-07-01 |
What the finished NCT03785548 record still lists
NCT03785548 is an observational study that tracks outcomes without assigning an intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Usage of a mirror is the first listed.
NCT03785548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03785548 about?
NCT03785548 is a clinical study titled "Utilization of the Mirror During Pelvic Exams". This is a prospective cohort study to determine if using a birthing mirror during the patient's pelvic examination decreases patients's degree of vulnerability and discomfort.
What is the current status of trial NCT03785548?
This trial is currently completed. The enrollment target is 147 participants. The study started on 2019-04-15. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT03785548?
The interventions under investigation include: Usage of a mirror (OTHER).
Who is sponsoring clinical trial NCT03785548?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI